Kingdom of Saudi Arabia Transdermal Skin Patches Market: Snapshot
Traditional drug delivery methods like capsules, pills, liquids, intravenous needles and powders are often ineffective and may result in undesirable side effects. Transdermal delivery constitutes an important and effective route for new drug delivery. The patches can be placed anywhere on the body and can be worn for as little as 7 hours to as long as one week, depending on its therapeutic indication. The medicated adhesive patches are designed in such a way that they attach comfortably to the surface of the skin, which helps the patient use the patches for prolonged periods. In light of these reasons, the Saudi Arabia transdermal skin patches market, which was valued at US$44.96 mn in 2016 is expected to be worth US$67.41 mn by the end of 2025. The market is slated to register a CAGR of 4.7% between 2017 and 2025.
Transdermal patches offer several advantages as compared to conventional drug delivery methods like reduced side effects caused due use of oral tablets or pills. They increase the bioavailability of the drug as substance need not be digested first. This helps in keeping the substance chemically unchanged which enable direct access of the drug to the region of the body where it can take effect via the bloodstream. This helps in avoiding first-pass effect or the initial metabolism and filtration by the liver. Another advantage of transdermal patches is that they release the drug constantly and continuously for long durations, which means that the patient need not worry about taking pills several times a day.
The products available in the Saudi Arabia transdermal skin patches are drug in adhesive, matrix, reservoir, and vapor matrix. Of these, the matrix segment held a dominant share in the overall market and is expected to account for a share of 35.1% in terms of revenue by the end of 2025. This rise will be attributable to the shifting preference for matrix systems to make patches for volatile molecules under controlled release settings. The phenomenal growth of this segment will be attributable to the non-toxic and non-antagonistic characteristics of polymer matrix options, which are known to diffuse drug with controlled precision.
Transdermal Skin Patches Most Commonly Used for Pain Relief
By way of application, the Saudi Arabia transdermal skin patches market has been divided into pain relief, hormone replacement therapy, nicotine cessation, motion sickness, cardiovascular disorders, neurological disorders, and others. Accounting for the dominant share by the end of the forecast period, the pain relief segment will generate the highest revenue by 2025. This can be attributed to growing usage of local pain relief patches. Such patches provide safe and controlled drug release to affected area, rendering them the preferred choice among comorbid and cancer patients. The cardiovascular disorders segment will also hold a major share in the transdermal skin patches market in Saudi Arabia owing to the rising number of patients with cardiovascular disorders in the region. Hormone replacement therapy is observed to be a highly lucrative segment, analysts find.
Transdermal skin patches are mostly sold through distribution channels such as retail pharmacies, hospital pharmacies, and online pharmacies. In Saudi Arabia, hospital pharmacies take the lead as the most prominent distribution channel in terms of revenue thanks to rising government initiatives to improve the healthcare landscape in the region and rapidly increasing number of healthcare facilities. Retail pharmacies also hold a valuable share in the transdermal skin patches market, attributed to growing investments by pharmaceutical companies to set up more pharmacies in Saudi Arabia. The online pharmacies segment is gaining much traction despite being in a nascent stage.
The competition in the Saudi Arabia transdermal skin patches market is poised to intensify as companies operating in the market are make large investments in research and development of better and advanced products. Some of the key players shaping the trajectory of the overall market are Johnson & Johnson, Novartis, Teva Pharmaceuticals, Mylan, Luye Pharma, Purdue Pharma, Hisamitsu Pharmaceutical, and Mundipharma.
Transdermal Skin Patches Market to Open New Vistas in Drug Delivery Systems
Applications of transdermal skin patches or transdermal patches have come a long way in their business prospects. The strides are notably fueled by advances made in skin science and a growing body of evidence-based studies. They have shown promise in cosmetics, topical, and transdermal drug delivery systems. Of late, they have attracted lodes of research interest among pharma companies, the reason having to do with the salient benefits transdermal route offers in sustained as well as controlled delivery of certain drugs. Over the past five years, having been acknowledged these systemic benefits, the U.S. FDA has approved a number of transdermal skin patches. The transdermal skin patches market continues to make strides with new applications being tested, particularly in pharmaceutical industry. A notable and recent case in point is the harnessing transdermal patches for the delivery of small drug molecules. Strides in transdermal drug delivery systems will pave way to new avenues, backed by the advent of novel biomaterials. Over the years, natural polymers such as hydrogels have been tested for their film-forming and bio-adhesive characteristics that can be used for the delivery. Cellulose and its derivatives are an important category of materials used in product development in the transdermal skin patches market.
The COVID-19 pandemic and its outbreaks in regions across the world have caused dramatic impacts on the macroeconomic and macroeconomic fundamentals of businesses in countries. Firm activities were severely hampered due to lockdowns and restrictions imposed by governments on trade and production activity. Some companies across the market value chain are witnessing new opportunities latent in the challenges and are targeting new consumer propositions to garner profits. Forward-looking companies have been mulling over new strategic frameworks to aid their decision-making in a largely uncertain times. This will enable them to fight off the aftermath of the economic crisis in the postpandemic world. Governments are also taking cognizance of these disruptions are expected to frame policies accordingly.
The transdermal skin patches market has been segmented as follows:
|
by Product Type |
|
|
by Application |
|
|
by Distribution Channel |
|
|
by Geography |
|
1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
3 Executive Summary
3.1 KSA Transdermal Skin Patches: Market Snapshot
3.2 Market Share Analysis by Application, 2016
4 Market Overview
4.1 Market Overview
4.2 Key Industry Events
4.3 KSA Transdermal Skin Patches Market: Market Outlook
5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.2.1 Increasing geriatric population
5.2.2 Ongoing developments in transdermal drug delivery system
5.2.3 Growing preference for self-administration of drugs
5.2.4 Improved efficacy as compared to other routes of drug administration
5.2.5 Increasing inclination toward pain free drug delivery
5.3 Restraints
5.3.1 Growing abuse of transdermal patches
5.3.2 Side effects associated with use transdermal patches
5.4 Opportunities
5.4.1 Increasing opportunities for generic players due to patent expiration
5.4.2 Growing areas of applications
5.5 Macro Factors Affecting Transdermal Skin Patches Market in KSA
5.5.1 Government initiatives for health care reforms
5.5.2 High prevalence of lifestyle diseases
5.5.3 Measures for encouraging investments in pharmaceutical sector
5.6 Key Trends
5.7 KSA Transdermal Skin Patches Market Size (US$ Mn) Forecast, 2017–2025
5.8 Transdermal Skin Patches Market: Porter’s Five Force Analysis
5.9 Transdermal Skin Patches Market: Supply Chain Analysis
5.10 Regulatory Scenario in Saudi Arabia
5.11 Saudi Arabia Healthcare Market Trends Analysis
5.12 Transdermal skin patch product insights
5.13 Customer Purchase: Decision Making Process
5.14 Transdermal Skin Patches Market: Analysis of Challenges for Factory Set Up
5.15 Raw material selection for transdermal skin patch manufacture
5.16 Transdermal Skin Patches Market: Factory Set Up Process
5.17 Transdermal Skin Patches Market: Market Share, by Key Players, 2016
6 KSA Transdermal Skin Patches Market Analysis, by Product Type
6.1 Introduction
6.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Product Type
6.3 KSA Transdermal Skin Patches Market Forecast, by Product Type
6.3.1 Drug in Adhesive
6.3.2 Matrix
6.3.3 Reservoir
6.3.4 Vapor
6.4 Market Attractiveness Analysis, by Product Type
7 KSA Transdermal Skin Patches Market Analysis, by Application
7.1 Introduction
7.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Application
7.3 KSA Transdermal Skin Patches Market Forecast, by Application
7.3.1 Pain Relief
7.3.2 Nicotine Cessation
7.3.3 Hormone replacement therapy
7.3.4 Motion Sickness
7.3.5 Neurological Disorders
7.3.6 Cardiovascular Disorders
7.3.7 Others
7.4 Market Attractiveness Analysis, by Application
8 KSA Transdermal Skin Patches Market Analysis, by Distribution Channel
8.1 Introduction
8.2 KSA Transdermal Skin Patches Market Value Share Analysis, by Distribution Channel
8.3 KSA Transdermal Skin Patches Market Forecast, by Distribution Channel
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Market Attractiveness Analysis, by Distribution Channel
9 Company Profiles
9.1 Teva Pharmaceutical Industries Ltd.
9.1.1. Company Overview (HQ, Business Segments, Employee Strength)
9.1.2. Business Overview
9.1.3. Product Portfolio
9.1.4. Financial Overview
9.1.5. SWOT Analysis
9.1.6. Strategic overview
9.2 Luye Pharma Group Ltd.
9.2.1. Company Overview (HQ, Business Segments, Employee Strength)
9.2.2. Business Overview
9.2.3. Product Portfolio
9.2.4. Financial Overview
9.2.5. SWOT Analysis
9.2.6. Strategic overview
9.3 Hisamitsu Pharmaceutical Co., Inc.
9.3.1. Company Overview (HQ, Business Segments, Employee Strength)
9.3.2. Business Overview
9.3.3. Product Portfolio
9.3.4. Financial Overview
9.3.5. SWOT Analysis
9.3.6. Strategic overview
9.4 Novartis AG
9.4.1. Company Overview (HQ, Business Segments, Employee Strength)
9.4.2. Business Overview
9.4.3. Product Portfolio
9.4.4. Financial Overview
9.4.5. SWOT Analysis
9.4.6. Strategic overview
9.5 Mylan N.V.
9.5.1. Company Overview (HQ, Business Segments, Employee Strength)
9.5.2. Business Overview
9.5.3. Product Portfolio
9.5.4. Financial Overview
9.5.5. SWOT Analysis
9.5.6. Strategic overview
9.6 Johnson & Johnson
9.6.1. Company Overview (HQ, Business Segments, Employee Strength)
9.6.2. Business Overview
9.6.3. Product Portfolio
9.6.4. Financial Overview
9.6.5. SWOT Analysis
9.6.6. Strategic overview
9.7 Mundipharma International Ltd
9.7.1. Company Overview (HQ, Business Segments, Employee Strength)
9.7.2. Business Overview
9.7.3. Product Portfolio
9.7.4. Financial Overview
9.7.5. SWOT Analysis
9.7.6. Strategic overview
9.8 Purdue Pharma L.P.
9.8.1. Company Overview (HQ, Business Segments, Employee Strength)
9.8.2. Business Overview
9.8.3. Product Portfolio
9.8.4. Financial Overview
9.8.5. SWOT Analysis
9.8.6. Strategic overview
List of Figures
Figure 01: Saudi Arabia Transdermal Skin Patches Market Size (US$ Mn) Forecast, 2017–2025
Figure 02: Transdermal Skin Patches Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 03: KSA Drug in Adhesive Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 04: KSA Matrix Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 05: KSA Reservoir Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 06: KSA Vapor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 07: Transdermal Skin Patches Market Attractiveness Analysis, by Product Type, 2016
Figure 08: Transdermal Skin Patches Market Value Share Analysis, by Application, 2017 and 2025
Figure 09: KSA Pain Relief Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: KSA Nicotine Cessation Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: KSA Hormone replacement therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: KSA Motion Sickness Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: KSA Neurological Disorders Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: KSA Cardiovascular Disorders Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: KSA Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Transdermal Skin Patches Market Attractiveness Analysis, by Application, 2015
Figure 17: Transdermal Skin Patches Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 18: KSA Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025
Figure 19: KSA Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025
Figure 20: KSA Online Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2025
Figure 21: Transdermal Skin Patches Market Attractiveness Analysis, by Distribution Channel, 2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Transdermal Skin Patches Market
